Phase 3 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female and aged 18 or older at the time of joining the trial.
- People who have been diagnosed with a malignant (cancerous) ovarian tumour confirmed by a tissue sample, where the cancer appears to be at an early stage (FIGO stage I or II), and who are scheduled for surgery to determine how far the cancer has spread.
- People with a suspected early-stage malignant ovarian tumour (FIGO stage I or II) who will undergo exploratory surgery and a biopsy, and if that biopsy confirms cancer, will then proceed to staging surgery.
- People who have signed a consent form agreeing to take part before any trial-related procedures begin.
Who may not be able to join:
- People who have not given consent, or who have withdrawn their consent to participate.
- People under 18 years of age at the time of joining.
- People who have previously had vascular surgery on the aorta, the large vein running down the body (vena cava), or the blood vessels in the pelvis.
- People who have previously had surgery on the lymph nodes in the pelvic or para-aortic region (the area alongside the large abdominal blood vessels).
- People with a previous history of lymphoma (a type of cancer affecting the lymphatic system).
- People who have previously had a tumour in the abdomen or pelvis.
- People who have a known allergy to either Tc99 (a radioactive tracer) or ICG (a dye used in medical imaging).
- People who are pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +34961246731
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Negative predictive value of the sentinel lymph node technique.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.